Abionic Appoints Patrick Pestalozzi as New CEO to Propel Company into
- ICU
- 22/02/2024
Abionic Appoints Patrick Pestalozzi as New CEO to Propel Company into Next Growth Phase
READ MOREAbionic Appoints Patrick Pestalozzi as New CEO to Propel Company into Next Growth Phase
READ MORERare Diseases: No Innovative Therapies Without Research
READ MOREIntensive Care Consultant to Lead NIHR's National Research Collaboration Programme
READ MORE7th Annual Anesthesiology Update 2024
READ MORECell-based therapies, particularly mesenchymal stromal cells (MSCs), hold significant promise for treating acute respiratory distress syndrom
READ MORESYNCOPE 2024- International Interdisciplinary Symposium
READ MOREMasimo SET® Pulse Oximetry Accurate Across Black & White Subjects, Even in Low Perfusion
READ MORE